StockVS

Butterfly Network, Inc. (BFLY) Stock Analysis

Healthcare

Butterfly Network, Inc.

$4.54

+$0.07 (+1.57%)

Last Updated: May 26, 2026

Price History

Analysis

Company Overview

Butterfly Network, Inc. operates as a developer, manufacturer, and commercializer of ultrasound imaging solutions designed for both United States and international markets. The company specializes in medical devices, specifically focusing on handheld probes integrated with clinical workflows to perform whole-body imaging. As a public entity within the healthcare sector, this classification places the firm in an industry characterized by high regulatory standards and significant capital requirements for research and development. The company currently possesses a market capitalization of $1.08 billion, generates annual revenue of $97.61 million, and employs 220 individuals. These financial figures indicate that while the company has achieved a substantial market valuation, its revenue base remains relatively modest compared to large-cap medical device peers, suggesting it operates as a mid-sized player with significant growth potential inherent in its niche technology.

Financial Health

The company reported revenue of $97.61 million over the trailing twelve months, yet this revenue generated a net income of -$77,064,000 and an EBITDA of -$54,158,000. The substantial gap between the positive revenue figure and the deeply negative net income reveals a cost structure where operating expenses and taxes heavily outweigh gross profits, resulting in a loss for every dollar earned. Despite the accounting losses, the company maintains positive free cash flow of $12.72 million, which signifies that the business is generating actual cash from operations sufficient to cover capital expenditures. This positive cash flow provides a degree of financial flexibility that allows the company to fund operations and potential R&D initiatives without immediate reliance on external equity financing. The gross margin stands at 64.7%, indicating strong pricing power or low cost of goods sold relative to sales, while the operating margin of -36.1% and profit margin of -79.0% highlight severe inefficiencies in covering overhead and total expenses. On the balance sheet, the company holds $150.49 million in cash against $20.40 million in debt, supported by a debt-to-equity ratio of 10.41 which, despite the high ratio, is mitigated by the massive cash cushion. The current ratio of 3.83 indicates a very strong liquidity position, suggesting the company has more than three times the assets available to cover its short-term liabilities. Finally, the return on equity is -42.2% and the return on assets is -13.2%, metrics that reveal that management is currently destroying value relative to the capital invested and the total asset base due to persistent operational losses.

Valuation Assessment

Valuation metrics for Butterfly Network present a complex picture given the absence of trailing earnings, resulting in a trailing P/E ratio that is effectively N/A and a forward P/E of -42.40. The negative forward P/E implies that analysts or the market is pricing in a future where earnings are expected to be negative or that the stock is valued primarily on revenue growth and intangible assets rather than current profitability. The price-to-book ratio is 5.49, which indicates that the market is valuing the company at a significant premium over its book value, reflecting high expectations for future technology commercialization despite current losses. Alternative valuation metrics such as the price-to-sales ratio of 11.06 and an EV/EBITDA of -17.53 suggest that the stock is being priced based on its revenue generation capabilities rather than earnings power. The stock trades with a 52-week high of $5.03 and a 52-week low of $1.32, and while the exact current price is not listed in the provided facts, the wide trading range indicates significant price volatility. The beta value of 2.33 explains that the stock price is expected to be highly volatile, moving with more than twice the magnitude of the broader market, which introduces substantial risk for investors holding this position.

Growth & Income

Revenue growth for the trailing twelve months is 41.0%, while earnings growth is listed as N/A due to the company's current net loss status. Since the earnings growth rate cannot be calculated against a positive baseline, the revenue growth stands as the primary indicator of expansion, implying that the company is scaling its sales volume rapidly even before achieving profitability. As the dividend yield is N/A and the payout ratio is 0.0%, the company does not distribute dividends to shareholders, which means it retains all earnings to reinvest into growth initiatives rather than providing income to investors. This reinvestment strategy is typical for pre-profitable technology firms that prioritize expanding their market share and refining their products over returning cash to capital providers. The overall growth and income profile is characterized by aggressive top-line expansion funded by existing cash reserves, with no current income distribution to shareholders.

Peer Comparison

Butterfly Network, Inc. (BFLY) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Butterfly Network, Inc. BFLY $1.19B N/A
Abbott Laboratories ABT $150.96B 24.3
Stryker Corporation SYK $119.99B 36.2
Medtronic plc MDT $99.63B 21.7

The Medical Devices industry average P/E ratio is 60.2x. Butterfly Network, Inc. trades at a P/E of N/A.

This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.

About Butterfly Network, Inc.

Butterfly Network, Inc. develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. The company offers Butterfly iQ+ and iQ3 ultrasound devices that can perform whole-body imaging on a single handheld probe integrated with the clinical workflow, and accessible on a user's smartphone, tablet, and almost any hospital computer system; Butterfly Move, merging the mobility of a handheld with the stability of a full cart system; and iQ+ Bladder, a specialty product for bladder scanning market. It also provides Compass AI which offers one system to connect every device, workflow, and department; ScanLab, an AI-powered educational platform that provides written walkthroughs and reference imagery to guide real-time educational scanning; and Butterfly iQ+/iQ3 Vet, a third generation handheld ultrasound system. It sells and markets its products through a direct sales force, distributors, and e-commerce channels. Butterfly Network, Inc. was founded in 2011 and is headquartered in Burlington, Massachusetts.

Visit website →

Key Statistics

Market Cap
$1.19B
P/E Ratio
N/A
52-Week High
$5.72
52-Week Low
$1.32
Avg Volume
4.89M
Beta
2.28

Data provided by Yahoo Finance via yfinance. Updated daily.

Company Info

Exchange
NYSE
Country
United States
Employees
220